Treatment of glucocorticoid-induced osteoporsis

about

Premenopausal bone health: osteoporosis in premenopausal women.Immunosuppressants and Male Reproduction.

P2860

Q34069758-08EEA4DE-0A03-42D6-8FA9-C074D91F49AD Q46236864-A290A96F-17D1-48F6-B18D-1BF25C2401DE

P2860

Treatment of glucocorticoid-induced osteoporsis

Item

http://www.wikidata.org/entity/Q36056932

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Treatment of glucocorticoid-induced osteoporsis

@ast

Treatment of glucocorticoid-induced osteoporsis

@en

type

Item

label

Treatment of glucocorticoid-induced osteoporsis

@ast

Treatment of glucocorticoid-induced osteoporsis

@en

prefLabel

Treatment of glucocorticoid-induced osteoporsis

@ast

Treatment of glucocorticoid-induced osteoporsis

@en

P1476

Treatment of glucocorticoid-induced osteoporsis

@en

P2093

Andrea Giustina

http://www.w3.org/2001/XMLSchema#string

Ernesto Canalis

http://www.w3.org/2001/XMLSchema#string

Gherardo Mazziotti

http://www.w3.org/2001/XMLSchema#string

P2860

Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years.

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol.

Glucocorticoid-induced osteoporosis.

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

QALYfying the value of life.

The Vitamin D requirement in health and disease.

Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis.

Growth hormone in glucocorticoid-induced osteoporosis.

P304

27-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1759720X09343222

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ernesto Canalis

John P. Bilezikian

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22870425

http://www.w3.org/2001/XMLSchema#string

P932

3382670

http://www.w3.org/2001/XMLSchema#string

Treatment of glucocorticoid-induced osteoporsis

about

P2860

P2860

Treatment of glucocorticoid-induced osteoporsis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932